Literature DB >> 26428212

Spermatogenesis in tumor-bearing testes in germ cell testicular cancer patients.

K Suzuki1, T Shin2, Y Shimomura2, T Iwahata2, H Okada2.   

Abstract

STUDY QUESTION: What are the factors that might indicate a greater likelihood of success in oncologic testicular sperm extraction (onco-TESE)? SUMMARY ANSWER: Smaller tumor diameter and greater noncancerous testicular tissue width (NCTW) are positive predictors of spermatogenesis in patients with testicular germ cell tumors (TGCTs). WHAT IS KNOWN ALREADY: Onco-TESE is a key modality for fertility preservation in cases of inadequate pretreatment sperm collection and azoospermic men with testicular cancer. TGCTs are known to reduce sperm quality such that ∼ 10% of these patients are azoospermic, making surgical TESE at the same time as orchiectomy their only means of fertility preservation. STUDY DESIGN, SIZE, DURATION: This study is a retrospective analysis performed in a single university hospital from 2002 to 2014. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Participants were 102 male patients (104 testes) who underwent inguinal orchiectomy and were diagnosed with a germinoma. In each specimen, the Johnsen Score Count (JSC) in seminiferous tubules at each established distance from the tumor margin (1, 2.5, 5, 7.5, 10 and 12.5 mm) was determined. We analyzed the relations between age, tumor histopathologic type, tumor size (maximum diameter), distance from the tumor, non-tumor tissue width and JSC. MAIN RESULTS AND THE ROLE OF CHANCE: The 104 specimens consisted of 78 seminomas and 26 non-seminomatous TGCTs. The mean ± SD JSC was 4.7 ± 2.4 in seminomas and 3.9 ± 2.5 in non-seminomatous germ cell tumors, with no significant difference between the two subtypes. Single regression analysis showed that tumor diameter was significantly negatively correlated with spermatogenesis (RC = -0.422, P < 0.001). Multiple linear regression analysis also showed that tumor diameter had a negative influence on spermatogenesis (RC = -0.437, P < 0.001). The greater the distance the seminiferous tubules from the tumor, the better the preservation of spermatogenesis. Mature spermatozoa were identified in 93.0% of patients with a NCTW ≥ 7.5 mm and in 41.3% of those with NCTW < 7.5 mm (P < 0.001). LIMITATIONS, REASONS FOR CAUTION: Study data were obtained retrospectively, which might have affected the quality of data. We were unable to compare spermatogenesis determined using preoperative seminograms with that determined histopathologically. It was not possible to evaluate spermatogenesis in the total volume of noncancerous testicular tissue. WIDER IMPLICATIONS OF THE
FINDINGS: When Onco-TESE is conducted at sites distant from tumors, the rate of sperm extraction is high and contamination by tumor cells can be prevented. By measuring non-testicular cancerous margin before the operation, the possibility of sperm extraction can be predicted and biopsy of the contralateral testis can be considered based on the results.
© The Author 2015. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  infertility; seminiferous tubules; spermatogenesis; testicular germ cell tumor; testicular sperm extraction

Mesh:

Year:  2015        PMID: 26428212     DOI: 10.1093/humrep/dev250

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Microdissection testicular sperm extraction in Japanese patients with persistent azoospermia after chemotherapy.

Authors:  Takeshi Shin; Tomohiro Kobayashi; Yukihito Shimomura; Toshiyuki Iwahata; Keisuke Suzuki; Takashi Tanaka; Mai Fukushima; Megumi Kurihara; Akane Miyata; Yoshitomo Kobori; Hiroshi Okada
Journal:  Int J Clin Oncol       Date:  2016-06-15       Impact factor: 3.402

2.  Comprehensive Analysis Identifies Ameloblastin-Related Competitive Endogenous RNA as a Prognostic Biomarker for Testicular Germ Cell Tumour.

Authors:  Tianxiang Geng; Catherine Anne Heyward; Xi Chen; Mengxue Zheng; Yang Yang; Janne Elin Reseland
Journal:  Cancers (Basel)       Date:  2022-04-07       Impact factor: 6.575

Review 3.  Preservation of fertility of adult male cancer patients treated with chemotherapy.

Authors:  Koji Kawai; Hiroyuki Nishiyama
Journal:  Int J Clin Oncol       Date:  2018-10-23       Impact factor: 3.402

4.  Successful onco-testicular sperm extraction from a testicular cancer patient with a single testis and azoospermia.

Authors:  Shinnosuke Kuroda; Takuya Kondo; Kohei Mori; Kengo Yasuda; Takuo Asai; Hiroyuki Sanjo; Hiroyuki Yakanaka; Teppei Takeshima; Takashi Kawahara; Yoshitake Kato; Yasuhide Miyoshi; Hiroji Uemura; Akira Iwasaki; Yasushi Yumura
Journal:  Clin Exp Reprod Med       Date:  2018-03-30

5.  Onco-testicular sperm extraction (Onco-TESE) from a single testis with metachronous bilateral testicular cancer: a case report.

Authors:  Itsuto Hamano; Shingo Hatakeyama; Rika Nakamura; Rie Fukuhara; Daisuke Noro; Hiroko Seino; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Yoshihito Yokoyama; Chikara Ohyama
Journal:  Basic Clin Androl       Date:  2018-01-25

6.  Sperm banking before gonadotoxic treatment: is it worth the effort?

Authors:  Kilian Vomstein; Elisabeth Reiser; Germar M Pinggera; Peter Toerzsoek; Susanne Deininger; Thomas Kriesche; Wolfgang Biasio; Lukas Lusuardi; Bettina Toth
Journal:  Asian J Androl       Date:  2021 Sep-Oct       Impact factor: 3.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.